| | | 54277 | | 10.12.1997 | | Boehringer Ingelheim (Schweiz) GmbH | | 22.12.2006 | | | | | | | | | | | 01.08. | | | | 01.08. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Sifrol 0,125 mg | Tabletten | Tabletten (Pramipexol Dihydrochlorid Monohydrat 0.125 mg) | N04BC05 | PI | | 02 | Sifrol 0,25 mg | Tabletten | Tabletten (Pramipexol Dihydrochlorid Monohydrat 0.25 mg) | N04BC05 | PI | | 03 | Sifrol 1,0 mg | Tabletten | Tabletten (Pramipexol Dihydrochlorid Monohydrat 1 mg) | N04BC05 | PI | | 05 | Sifrol 1,5 mg | Tabletten | Tabletten () | N04BC05 | PI | | 06 | Sifrol 0,5 mg | Tabletten | Tabletten (Pramipexol Dihydrochlorid Monohydrat 0.5 mg) | N04BC05 | PI |
|
|
